CABOZANTINIB
cabozantinib 40 mg tablet, 30
CABOZANTINIB (11368H)
11368H
Manner of administration:Oral
Restriction 17794
Indication: Stage IV renal cell carcinoma (RCC)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $9,472.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Cabometyx | |||||